ATA106679A - Verfahren zur herstellung einer waesserigen loesung eines rafoxanide-polyvinyl- pyrrolidon-komplexes - Google Patents

Verfahren zur herstellung einer waesserigen loesung eines rafoxanide-polyvinyl- pyrrolidon-komplexes

Info

Publication number
ATA106679A
ATA106679A AT106679A AT106679A ATA106679A AT A106679 A ATA106679 A AT A106679A AT 106679 A AT106679 A AT 106679A AT 106679 A AT106679 A AT 106679A AT A106679 A ATA106679 A AT A106679A
Authority
AT
Austria
Prior art keywords
rafoxanide
polyvinyl
producing
aqueous solution
pyrrolidone complex
Prior art date
Application number
AT106679A
Other languages
English (en)
Other versions
AT363600B (de
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ATA106679A publication Critical patent/ATA106679A/de
Application granted granted Critical
Publication of AT363600B publication Critical patent/AT363600B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/609Amides, e.g. salicylamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0106679A 1978-02-13 1979-02-12 Verfahren zur herstellung einer waesserigen loesung eines rafoxanide-polyvinylpyrrolidon-komplexes AT363600B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/876,968 US4128632A (en) 1978-02-13 1978-02-13 Solubilization of Rafoxanide

Publications (2)

Publication Number Publication Date
ATA106679A true ATA106679A (de) 1981-01-15
AT363600B AT363600B (de) 1981-08-10

Family

ID=25368975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0106679A AT363600B (de) 1978-02-13 1979-02-12 Verfahren zur herstellung einer waesserigen loesung eines rafoxanide-polyvinylpyrrolidon-komplexes

Country Status (18)

Country Link
US (1) US4128632A (de)
EP (1) EP0003682B1 (de)
JP (1) JPS54117019A (de)
AR (1) AR221862A1 (de)
AT (1) AT363600B (de)
AU (1) AU522422B2 (de)
DE (1) DE2962602D1 (de)
DK (1) DK57479A (de)
HU (1) HU177873B (de)
IE (1) IE47833B1 (de)
IT (1) IT1113720B (de)
NZ (1) NZ189536A (de)
OA (1) OA06239A (de)
PH (1) PH13191A (de)
PL (1) PL114317B1 (de)
YU (1) YU25679A (de)
ZA (1) ZA79597B (de)
ZW (1) ZW3579A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
YU43349B (en) * 1983-03-16 1989-06-30 Boehringer Ingelheim Ltd Process for making a watersoluble, pharmaceutically acceptible dispersion of chlortalidone in solid state
US4933360A (en) * 1983-03-16 1990-06-12 Boehringer Ingelheim Pharmaceuticals, Inc. Novel chlorthalidone process and product
EP0305384A4 (de) * 1986-05-02 1989-06-13 Gaf Corp Wasserlösliche polyvinyl-lactam-arzneimittel-komplexe.
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
EP1129713A1 (de) * 2000-02-29 2001-09-05 New Pharma Research Sweden AB Tierärztliche Zusammensetzungen zur Behandlung von Parasiterkrankungen
GB2386066A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
DE102010051404B4 (de) 2010-11-16 2017-08-31 Marc de Cocq Verwendung von substituierten Salicylaniliden zur Behandlung von Fischen
DE102012009572A1 (de) 2012-05-15 2013-11-21 Marc de Cocq Die Verwendung von Glycerol-Formal als Lösungsvermittler für pharmazeutische Wirkstoffe bei der Bekämpfung von Fischkrankheiten
CN106176586A (zh) * 2016-07-22 2016-12-07 柳州市柳南区安顺养殖协会 一种牛羊用抗寄生虫病碘醚柳胺透皮溶液

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL184257C (nl) * 1974-06-19 1989-06-01 Merck & Co Inc Werkwijze voor het bereiden van rafoxanide preparaten.

Also Published As

Publication number Publication date
IE790259L (en) 1979-08-13
DE2962602D1 (en) 1982-06-09
US4128632A (en) 1978-12-05
YU25679A (en) 1984-02-29
ZW3579A1 (en) 1980-09-10
EP0003682B1 (de) 1982-04-28
IE47833B1 (en) 1984-06-27
PH13191A (en) 1980-01-16
IT7947942A0 (it) 1979-02-08
EP0003682A1 (de) 1979-08-22
AT363600B (de) 1981-08-10
AU522422B2 (en) 1982-06-03
PL114317B1 (en) 1981-01-31
NZ189536A (en) 1981-02-11
PL213352A1 (de) 1979-12-03
HU177873B (en) 1982-01-28
AR221862A1 (es) 1981-03-31
JPS54117019A (en) 1979-09-11
DK57479A (da) 1979-08-14
ZA79597B (en) 1980-10-29
IT1113720B (it) 1986-01-20
OA06239A (fr) 1981-06-30
AU4391479A (en) 1979-08-23

Similar Documents

Publication Publication Date Title
AT387517B (de) Verfahren zur herstellung eines praeparates von para-aroyl-phenoxy-isobuttersaeurederivaten
AT363351B (de) Verfahren zur herstellung eines seils
AT366393B (de) Verfahren zur herstellung eines metallkatalysators
ATA280979A (de) Verfahren zur herstellung eines prophylaktikums
AT366083B (de) Verfahren zur herstellung eines klebstoffgemisches
ATA304479A (de) Verfahren zur herstellung eines oxidkomplexkatalysators
AT371833B (de) Verfahren zur herstellung einer iso-alpha-saeuren enthaltenden waesserigen mischung
AT358015B (de) Verfahren zur herstellung einer 2-arylpropion- saeure
AT363600B (de) Verfahren zur herstellung einer waesserigen loesung eines rafoxanide-polyvinylpyrrolidon-komplexes
AT370625B (de) Verfahren zur herstellung einer stabilen waesserigen injektionsloesung eines oxytetracyclin- -erdalkalimetall-chelats
AT374773B (de) Verfahren zur herstellung einer gereinigten ammoniummolybdatloesung
AT362986B (de) Verfahren zur herstellung eines homogenen waesserigen tierfuttermittels
AT370116B (de) Verfahren zur herstellung einer waesserigen kunststoffdispersion
ATA499079A (de) Verfahren zur herstellung eines synthetischen crepegarns
DD134079A5 (de) Verfahren zur herstellung eines baukoerpers
AT367071B (de) Verfahren zur herstellung eines katalysators
AT364462B (de) Verfahren zur herstellung einer kristallinen form eines cefamandolderivates
DD138506A1 (de) Verfahren zur herstellung einer waessrigen loesung
DD139335A3 (de) Verfahren zur herstellung eines freilagerfaehigen kalk-magnesium-duengemittels
AT352882B (de) Verfahren zur herstellung einer stabilisierten theophyllin enthaltenden waesserigen loesung
ATA282779A (de) Verfahren zur herstellung einer hetero- klischen verbindung
AT363594B (de) Verfahren zur herstellung eines neuen formamidkomplexes von 7-beta-(d-2-amino-2-phenylacetamido)-3-methylceph-3-emcarbonsaeure
AT345607B (de) Verfahren zur herstellung einer stabilen waesserigen ipronidazol-loesung
AT363588B (de) Verfahren zur herstellung einer stabilen sauren sekretinzubereitung
ATA653079A (de) Verfahren zur herstellung einer b-beta- -acylaminopenicillansaeure

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee